A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors
Titel:
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors
Auteur:
Bauer, Todd M. Moore, Kathleen N. Rader, Janet S. Simpkins, Fiona Mita, Alain C. Beck, J. Thaddeus Hart, Lowell Chu, Quincy Oza, Amit Tinker, Anna V. Imedio, Esteban Rodrigo Kumar, Sanjeev Mugundu, Ganesh Jenkins, Suzanne Chmielecki, Juliann Jones, Suzanne Spigel, David Fu, Siqing